The University Medical Center Utrecht (UMCU) in the Netherlands is monitoring COVID-19 patients in isolation rooms using Philips biosensor and patient monitoring technology. Together with Philips, UMCU has developed a solution to monitor these patients continuously yet remotely, reducing the number of times nursing staff need to enter the patient’s room. UMCU hopes this will reduce the risk of its nurses being infected with the coronavirus, as well as reducing the hospital’s consumption of personal protective equipment (PPE) such as single-use gloves, face masks and aprons. UMCU currently has 26 isolation beds equipped with Philips’ smart patient monitoring technology.
The system is supported by Philips’ automated early detection and warning solution (IntelliVue GuardianSoftware) (IntelliVue Guardian) – software that continuously analyzes data from Philips’ biosensors, ‘spot-check’ patient monitors and the nurse’s manual input to detect subtle deteriorations in a patient’s vital signs. Based on this analysis, the software generates an early-warning score that shows each individual patient’s status to their caregivers, allowing nursing staff to intervene at an early stage if necessary. Philips’ biosensor technology measures the patient’s position/posture, activity level, heart rate and respiratory rate. Its spot-check monitors measure the patient’s body temperature, blood pressure and blood oxygen saturation.